ethidium has been researched along with amsacrine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sumner, AT | 1 |
| Adachi, K; Andrea, JE; Morgan, AR | 1 |
| Drake, FH; Hofmann, GA; Mirabelli, CK | 1 |
| Larsen, CJ; Riou, G; Riou, JF; Vilarem, MJ | 1 |
| Baguley, BC; Davis, LM; Harvey, JD | 1 |
| Shall, S; Tavassoli, M; Tavassoli, MH | 1 |
| Baguley, BC; Le Bret, M | 1 |
| Kohn, KW; Mattern, MR; Pommier, Y; Schwartz, RE; Zwelling, LA | 1 |
| Heimpel, S; Hiller, KH; Hoehn, H; Poot, M | 1 |
| Sitailo, LA; Zagariya, AM | 1 |
| Falaschi, A; Ochem, A; Phan, TN; Tuteja, N; Tuteja, R | 1 |
| Phan, TN; Tuteja, N | 1 |
| Graves, DE | 1 |
13 other study(ies) available for ethidium and amsacrine
| Article | Year |
|---|---|
Inhibitors of topoisomerases do not block the passage of human lymphocyte chromosomes through mitosis.
Topics: Amsacrine; Camptothecin; Chromosome Aberrations; Chromosomes, Human; Daunorubicin; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Ellipticines; Ethidium; Etoposide; Humans; In Vitro Techniques; Lymphocytes; Mitosis; Mitoxantrone; Nalidixic Acid; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1992 |
Fluorometric assays for DNA topoisomerases and topoisomerase-targeted drugs: quantitation of catalytic activity and DNA cleavage.
Topics: Amsacrine; Animals; Antineoplastic Agents; Camptothecin; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Circular; DNA, Single-Stranded; DNA, Superhelical; Ethidium; Fluorescence; Fluorometry; Hydrogen-Ion Concentration; Kinetics; Novobiocin; Teniposide; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1991 |
Quantitative adaptation of the bacteriophage P4 DNA unknotting assay for use in the biochemical and pharmacological characterization of topoisomerase II.
Topics: Amsacrine; Bacteriophages; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Enzyme Inhibitors; Ethidium; Structure-Activity Relationship; Teniposide; Topoisomerase II Inhibitors | 1990 |
Characterization of the topoisomerase II-induced cleavage sites in the c-myc proto-oncogene. In vitro stimulation by the antitumoral intercalating drug mAMSA.
Topics: Amsacrine; Animals; Bacteriophage lambda; Cattle; DNA; DNA Restriction Enzymes; DNA Topoisomerases, Type II; DNA, Recombinant; Ethidium; Humans; Nucleic Acid Hybridization; Oncogenes; Proto-Oncogene Mas | 1986 |
Electron donor properties of the antitumour drug amsacrine as studied by fluorescence quenching of DNA-bound ethidium.
Topics: Acridines; Amsacrine; Depression, Chemical; DNA; Electrochemistry; Electrons; Ethidium; Fluorescence; Fluorometry; Poly dA-dT | 1987 |
Effect of DNA intercalators on poly(ADP-ribose) glycohydrolase activity.
Topics: Aminoacridines; Amsacrine; Animals; Chloroquine; Daunorubicin; DNA; Ellipticines; Ethacridine; Ethidium; Glycoside Hydrolases; Histones; Intercalating Agents; Kinetics; Proflavine; Swine; Thymus Gland; Tilorone | 1985 |
Quenching of DNA-ethidium fluorescence by amsacrine and other antitumor agents: a possible electron-transfer effect.
Topics: Aminoacridines; Amsacrine; Animals; Antineoplastic Agents; Cattle; Chemical Phenomena; Chemistry; DNA; DNA, Bacterial; DNA, Viral; Ethidium; Kinetics; Poly dA-dT; Spectrometry, Fluorescence; Structure-Activity Relationship; Thymus Gland | 1984 |
Changes in deoxyribonucleic acid linking number due to treatment of mammalian cells with the intercalating agent 4'-(9-acridinylamino)methanesulfon-m-anisidide.
Topics: Aminoacridines; Amsacrine; Animals; Benzamides; Cell Nucleus; Deoxyribonucleoproteins; DNA, Neoplasm; Ethidium; Intercalating Agents; Kinetics; Leukemia L1210; Mice; Novobiocin | 1984 |
Distinct patterns of cell cycle disturbance elicited by compounds interfering with DNA topoisomerase I and II activity.
Topics: Amsacrine; Bisbenzimidazole; Camptothecin; Cell Cycle; Cell Line; Distamycins; DNA; Dose-Response Relationship, Drug; Ethidium; Flow Cytometry; Humans; Intercalating Agents; Kinetics; Lymphocytes; Netropsin; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1995 |
The influence of antibiotics and antitumor agents on the relaxation activity of Pisum sativum leaf chloroplast topoisomerase I.
Topics: Amiloride; Amsacrine; Anti-Bacterial Agents; Antineoplastic Agents; Camptothecin; Chloroplasts; DNA Topoisomerases, Type I; DNA, Plant; Ethidium; Heparin; Indoles; Magnesium; Nalidixic Acid; Novobiocin; Pisum sativum; Polyamines; Topoisomerase I Inhibitors | 1995 |
Inhibition of DNA unwinding and ATPase activities of human DNA helicase II by chemotherapeutic agents.
Topics: Adenosine Triphosphatases; Amsacrine; Antineoplastic Agents; Aphidicolin; Camptothecin; Dactinomycin; Daunorubicin; DNA; DNA Helicases; Ellipticines; Enzyme Inhibitors; Ethidium; Etoposide; Genistein; Humans; Isoflavones; Nogalamycin; Novobiocin; Topoisomerase I Inhibitors | 1997 |
Inhibition of pea chloroplast DNA helicase unwinding and ATPase activities by DNA-interacting ligands.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Amsacrine; Camptothecin; Chloroplasts; Dactinomycin; Daunorubicin; DNA Helicases; Ellipticines; Ethidium; Etoposide; Genistein; Hydrolysis; Intercalating Agents; Ligands; Nogalamycin; Novobiocin; Pisum sativum | 1998 |
Targeting DNA through-covalent interactions of reversible binding drugs.
Topics: Amsacrine; Base Sequence; Binding Sites; Dactinomycin; DNA; DNA Topoisomerases, Type II; Drug Design; Ethidium; In Vitro Techniques; Intercalating Agents; Ligands; Models, Molecular; Nucleic Acid Conformation; Pharmaceutical Preparations; Photochemistry | 2001 |